English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This work was done as a part of safety assessment to determine the effects of Tartrazine E102 on some haematological indices, glucose levels and blood lipid profile in rats. An animal model was used as a basis for interpreting the situation in humans. Consequently, 40 albino rats were divided into 5 groups of 8 rats each. All the animals were fed rats’ mash and water and administered 0, 10, 20, 40 and 80mg/kg body weight of Tartrazine E102 respectively. Weekly measurements of body weight were recorded. Results obtained showed a significant reduction in body weight gain and blood glucose levels compared with the control. A non-dose dependent effect was observed on total cholesterol, LDL cholesterol, total white blood cells and monocytes. A slight but significant increase was observed in haematocrit at the highest dose levels. Conclusively, Tartrazine E102 exhibited a hypoglycemic effect in rats, no negative effect was observed on lipid profile. KEY WORDS : Tartrazine E102; glucose; haematological; cholesterol; triacylglycerol

Haematological Indices, Blood glucose levels and lipid profile of rats administered Tartrazine E102